Literature DB >> 17186016

The natural history of cervical HPV infection: unresolved issues.

Ciaran B J Woodman1, Stuart I Collins, Lawrence S Young.   

Abstract

The identification of high-risk human papillomavirus (HPV) types as a necessary cause of cervical cancer offers the prospect of effective primary prevention and the possibility of improving the efficiency of cervical screening programmes. However, for these opportunities to be realized, a more complete understanding of the natural history of HPV infection, and its relationship to the development of epithelial abnormalities of the cervix, is required. We discuss areas of uncertainty, and their possible effect on disease prevention strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17186016     DOI: 10.1038/nrc2050

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  301 in total

Review 1.  Estrogen and ERalpha: culprits in cervical cancer?

Authors:  Sang-Hyuk Chung; Silvia Franceschi; Paul F Lambert
Journal:  Trends Endocrinol Metab       Date:  2010-04-22       Impact factor: 12.015

2.  A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.

Authors:  Hyunwook Lee; Sarah A Brendle; Stephanie M Bywaters; Jian Guan; Robert E Ashley; Joshua D Yoder; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  HPV typing and its relation with apoptosis in cervical carcinoma from Indian population.

Authors:  M Shabbir Alam; Asgar Ali; Syed Jafar Mehdi; Nisreen Sherif Alyasiri; Zakia Kazim; Swaraj Batra; A K Mandal; M Moshahid Alam Rizvi
Journal:  Tumour Biol       Date:  2011-09-20

4.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

5.  Proteomic analysis of cervical cancer cells treated with suberonylanilide hydroxamic acid.

Authors:  Jianxiong He; Canhua Huang; Aiping Tong; Bin Chen; Zhi Zeng; Peng Zhang; Chunting Wang; Yuquan Wei
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

Review 6.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis.

Authors:  Samina Alam; Michael J Conway; Horng-Shen Chen; Craig Meyers
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Authors:  S L Sudenga; S Shrestha
Journal:  Int J Infect Dis       Date:  2013-02-27       Impact factor: 3.623

9.  Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum.

Authors:  Sze Chuen Cesar Wong; Thomas Chi Chuen Au; Sammy Chung Sum Chan; Charles Ming Lok Chan; Money Yan Yee Lam; Benny Chung Ying Zee; Wei Mei Pong; Anthony Tak Cheung Chan
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

10.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.